SUMMARY: Lloyd Mills, a 32-year-old with autism, cerebral palsy, and kidney disease, has faced prolonged hospitalization due to inadequate community support in Georgia. After being admitted to Grady Memorial Hospital for mental health issues, Mills waited over eight months for appropriate housing, highlighting the systemic failures of a state still grappling with the consequences of a 2010 Department of Justice lawsuit regarding care for people with developmental disabilities. Despite significant investments and improvements in services, challenges like workforce shortages and inadequate funding persist, often leaving individuals like Mills in hospitals, impacting their mental and physical well-being.

Read the full article

The post Georgians With Disabilities Are Still Being Institutionalized, Despite Federal Oversight appeared first on kffhealthnews.org

SUMMARY: President-elect Donald Trump nominated celebrity doctor Mehmet Oz to head the Centers for Medicare & Medicaid Services (CMS). Oz, known for his investments in healthcare, tech, and food companies, holds significant stakes in UnitedHealth Group, CVS Health, Amazon, and other companies involved in health insurance and pharmaceuticals, raising potential conflicts of interest. His financial ties include hospital stocks and pharmaceutical investments. Oz has expressed support for Medicare Advantage and criticized the food and healthcare industries. Critics question whether Oz can separate his financial interests from his role, particularly with companies doing business with the federal government.

Read the full article

The post TV’s Dr. Oz Invested in Businesses Regulated by Agency Trump Wants Him To Lead appeared first on kffhealthnews.org

SUMMARY: Florida’s plan to import lower-cost prescription drugs from Canada, approved by the FDA nearly a year ago, has yet to launch. Governor Ron DeSantis praised the program, anticipated to save state agencies up to $180 million, but officials lack a start date. Despite bipartisan support for drug importation, complications persist, including operational challenges and safety concerns from the pharmaceutical industry. DeSantis has filed lawsuits against the FDA for delays and Florida has already spent $50 million on the initiative with no drugs imported. Other states, like Colorado, face similar hurdles in establishing importation programs.

Read the full article

The post Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval appeared first on kffhealthnews.org